Current Headlines

1. OGT Expands NGS Offering With Targeted Familial Sequencing And Analysis
   5/30/2013

   Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, has extended its high-quality whole exome sequencing services with a targeted Familial Sequencing and Analysis Service.

2. Seminars, Technology Highlight CYTO 2013 Offerings From Beckman Coulter Life Sciences
   5/16/2013

   Presenting two seminars and seven poster sessions, Beckman Coulter Life Sciences will have a prominent role when CYTO 2013 convenes at the San Diego Convention Center May 18-22, 2013.

3. ILC Dover Receives ISO Class 7 Cleanroom Certification
   5/15/2013

   ILC Dover, the designer and manufacturer of NASA’s space suits and a wide range of engineered film and fabric products, announced recently it has received certification for its ISO Class 7 Clean Room.

4. Global Vision Selected By Pfizer For Worldwide Deployment Of Automated Proofreading Solutions
   5/14/2013

   Global Vision, the industry leader in the development of automated proofreading solutions, recently announced that it has been selected by Pfizer for worldwide deployment as its proofreading technology solution provider.

5. NanoPass Technologies Supports A CDC-Sponsored Phase 3 Study Of Polio Vaccine In Infants As Part Of its Global Health Initiative
   5/13/2013

   NanoPass Technologies Ltd. ("NanoPass"), a pioneer in intradermal (into-the-skin or ID) vaccine delivery solutions, is collaborating with the US Center of Disease Control and prevention (CDC) in conducting a large phase 3 trial of polio vaccine in infants in South East Asia.

6. U.S. FDA Grants Priority Review To Simeprevir (TMC435) For Combination Treatment Of Genotype 1 Chronic Hepatitis C
   5/13/2013

   Janssen Research & Development, LLC (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the New Drug Application (NDA) for simeprevir (TMC435), an investigational NS3/4A protease inhibitor administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease.

7. BioTek Responds To Growing AP Market Needs With New Taiwan Office
   5/13/2013

   BioTek Instruments, Inc., continues their expansion in the Asia Pacific region with the opening of BioTek Taiwan, located in the Neihu District of Taipei. Mr. Jack Lu (Lu Wen-Chung), previously with Tseng Hsiang Life Science, was named General Manager of BioTek Taiwan at its inception in mid-April.

8. Alligator Stem Cell Study Gives Clues To Tooth Regeneration
   5/13/2013

   Alligators may help scientists learn how to stimulate tooth regeneration in people, according to new research led by the Keck School of Medicine of USC. By Alison Trinidad

9. Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint In Diffuse Large B-Cell Lymphoma
   5/10/2013

   Eli Lilly and Company (NYSE: LLY) announced today Phase III clinical trial results from enzastaurin's PRELUDE study, which explored the molecule as a monotherapy in the prevention of relapse in patients with diffuse large B-cell lymphoma (DLBCL).

10. Voluntary Nationwide Recall Of 21 Lots Of Piperacillin And Tazobactam For Injection, USP 40.5 Grams Due To Possibility Of Precipitation / Crystallization In IV Bag Or IV Line Upon Reconstitution
    5/10/2013

    Apotex Corp. announced recently that it is conducting, on behalf of the manufacturer Hospira, Inc., a voluntary nationwide recall of 21 lots of Piperacillin and Tazobactam for Injection, USP 40.5 grams, NDC number 60505-0773-00 to the hospital / healthcare provider /user level.